Advertisement
Mitsubishi Corporation (MTSUY)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
At close: 03:42PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 48.09 |
| Open | 48.09 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 48.09 - 48.09 |
| 52 Week Range | 37.00 - 53.00 |
| Volume | |
| Avg. Volume | 562 |
| Market Cap | 67.048B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | 10.39 |
| EPS (TTM) | 4.63 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.42 (2.96%) |
| Ex-Dividend Date | Sep 28, 2023 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for MTSUY
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- MITSUBISHI CORP UNSPONS ADS REPAnalyst Report: Merck KGaAMerck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.RatingFair ValueEconomic Moat3 days agoMorningstar
ReutersWarren Buffett's stamp of approval helps Japan's Mitsubishi shed conglomerate stigma
Warren Buffett's vote of confidence in Japanese trading houses is helping Mitsubishi Corp overcome long-held investor wariness about its complex global business that covers everything from sausages to natural gas, a top executive said.
The Wall Street JournalHeineken’s 3Q Clears the Way for 2024 Prospects
Heineken’s 3Q performance was slightly weak, but the backed guidance and the likely absence of any major changes to consensus estimates should support share increases, Citi said.
The Wall Street JournalMitsubishi Motors to End Car Production in China
Mitsubishi Motors plans to end production of cars in China in response to sluggish sales amid stiff competition.
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.